US Patent Issued to Morphic Medical on Sept. 9 for "Therapeutic methods involving gastrointestinal implants" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,133, issued on Sept. 9, was assigned to Morphic Medical Inc. (Boston).

"Therapeutic methods involving gastrointestinal implants" was invented by Scott Schorer (Duxbury, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides combination therapies for treating a metabolic disorder, such as type 2 diabetes, obesity, and related comorbidities (e.g., NASH or NAFLD)) in an individual undergoing treatment with a gastrointestinal implant. The combination therapies described herein include methods for treating an individual with a gastrointestinal implant with a metabolic agent, a bariatric procedure, and/or a microbiota modulat...